Analyst consensus rating
Eledon Pharmaceuticals Analyst Rating: none
Direct answer
Eledon Pharmaceuticals's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.00.
Forecast evidence checked October 19, 2026.
Get free Eledon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.13
- Average price target
- $9.00
- High price target
- $12.00
- Low price target
- $7.00
- Low target gap
- +228.6%
- Target upside
- +322.5%
- High target gap
- +463.4%
- Target range width
- 234.7%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Eledon Pharmaceuticals?
Eledon Pharmaceuticals has a verified none consensus. The same dataset has an average price target of $9.00.
How far are Eledon Pharmaceuticals's low and high targets from the recorded price?
The low target implies +228.6%, while the high target implies +463.4%.
How many analysts are included in Eledon Pharmaceuticals's consensus?
The verified consensus includes 5 analysts.
How is Eledon Pharmaceuticals's target upside or downside calculated?
The average target of $9.00 is divided by the recorded price of $2.13, then one is subtracted to produce +322.5%. This does not guarantee a future return.
When was Eledon Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.